These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 32482619)
1. Diverse dystonin gene mutations cause distinct patterns of Yoshioka N; Kabata Y; Kuriyama M; Bizen N; Zhou L; Tran DM; Yano M; Yoshiki A; Ushiki T; Sproule TJ; Abe R; Takebayashi H Dis Model Mech; 2020 May; 13(5):. PubMed ID: 32482619 [TBL] [Abstract][Full Text] [Related]
2. Characterization of novel dystonia musculorum mutant mice: Implications for central nervous system abnormality. Horie M; Mekada K; Sano H; Kikkawa Y; Chiken S; Someya T; Saito K; Hossain MI; Nameta M; Abe K; Sakimura K; Ono K; Nambu A; Yoshiki A; Takebayashi H Neurobiol Dis; 2016 Dec; 96():271-283. PubMed ID: 27693510 [TBL] [Abstract][Full Text] [Related]
3. Roles of dystonin isoforms in the maintenance of neural, muscle, and cutaneous tissues. Yoshioka N Anat Sci Int; 2024 Jan; 99(1):7-16. PubMed ID: 37603210 [TBL] [Abstract][Full Text] [Related]
4. Dystonin-A3 upregulation is responsible for maintenance of tubulin acetylation in a less severe dystonia musculorum mouse model for hereditary sensory and autonomic neuropathy type VI. Lynch-Godrei A; De Repentigny Y; Gagnon S; Trung MT; Kothary R Hum Mol Genet; 2018 Oct; 27(20):3598-3611. PubMed ID: 29982604 [TBL] [Abstract][Full Text] [Related]
5. Disruption of actin-binding domain-containing Dystonin protein causes dystonia musculorum in mice. Horie M; Watanabe K; Bepari AK; Nashimoto J; Araki K; Sano H; Chiken S; Nambu A; Ono K; Ikenaka K; Kakita A; Yamamura K; Takebayashi H Eur J Neurosci; 2014 Nov; 40(10):3458-71. PubMed ID: 25195653 [TBL] [Abstract][Full Text] [Related]
6. Characterization of gastrointestinal pathologies in the dystonia musculorum mouse model for hereditary sensory and autonomic neuropathy type VI. Lynch-Godrei A; De Repentigny Y; Yaworski RA; Gagnon S; Butcher J; Manoogian J; Stintzi A; Kothary R Neurogastroenterol Motil; 2020 Apr; 32(4):e13773. PubMed ID: 31814231 [TBL] [Abstract][Full Text] [Related]
7. Disruption in the autophagic process underlies the sensory neuropathy in dystonia musculorum mice. Ferrier A; De Repentigny Y; Lynch-Godrei A; Gibeault S; Eid W; Kuo D; Zha X; Kothary R Autophagy; 2015; 11(7):1025-36. PubMed ID: 26043942 [TBL] [Abstract][Full Text] [Related]
8. Isoform-specific mutation in Dystonin-b gene causes late-onset protein aggregate myopathy and cardiomyopathy. Yoshioka N; Kurose M; Yano M; Tran DM; Okuda S; Mori-Ochiai Y; Horie M; Nagai T; Nishino I; Shibata S; Takebayashi H Elife; 2022 Aug; 11():. PubMed ID: 35942699 [TBL] [Abstract][Full Text] [Related]
9. Pathogenic DST sequence variants result in either epidermolysis bullosa simplex (EBS) or hereditary sensory and autonomic neuropathy type 6 (HSAN-VI). Khalesi R; Harvey N; Garshasbi M; Kalamati E; Youssefian L; Vahidnezhad H; Uitto J Exp Dermatol; 2022 Jun; 31(6):949-955. PubMed ID: 35276021 [TBL] [Abstract][Full Text] [Related]
10. Transgenic expression of neuronal dystonin isoform 2 partially rescues the disease phenotype of the dystonia musculorum mouse model of hereditary sensory autonomic neuropathy VI. Ferrier A; Sato T; De Repentigny Y; Gibeault S; Bhanot K; O'Meara RW; Lynch-Godrei A; Kornfeld SF; Young KG; Kothary R Hum Mol Genet; 2014 May; 23(10):2694-710. PubMed ID: 24381311 [TBL] [Abstract][Full Text] [Related]
11. The Lalonde R; Strazielle C J Neurogenet; 2023; 37(4):131-138. PubMed ID: 38465459 [No Abstract] [Full Text] [Related]
12. Sensory-motor circuit is a therapeutic target for Yoshioka N; Kurose M; Sano H; Tran DM; Chiken S; Tainaka K; Yamamura K; Kobayashi K; Nambu A; Takebayashi H Sci Adv; 2024 Jul; 10(30):eadj9335. PubMed ID: 39058787 [TBL] [Abstract][Full Text] [Related]
13. Disruption of dystonin in Schwann cells results in late-onset neuropathy and sensory ataxia. Horie M; Yoshioka N; Kusumi S; Sano H; Kurose M; Watanabe-Iida I; Hossain I; Chiken S; Abe M; Yamamura K; Sakimura K; Nambu A; Shibata M; Takebayashi H Glia; 2020 Nov; 68(11):2330-2344. PubMed ID: 32445516 [TBL] [Abstract][Full Text] [Related]
14. HSAN-VI: A spectrum disorder based on dystonin isoform expression. Lynch-Godrei A; Kothary R Neurol Genet; 2020 Feb; 6(1):e389. PubMed ID: 32042917 [TBL] [Abstract][Full Text] [Related]
15. Novel mutations in Manganelli F; Parisi S; Nolano M; Tao F; Paladino S; Pisciotta C; Tozza S; Nesti C; Rebelo AP; Provitera V; Santorelli FM; Shy ME; Russo T; Zuchner S; Santoro L Neurology; 2017 May; 88(22):2132-2140. PubMed ID: 28468842 [TBL] [Abstract][Full Text] [Related]
16. Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum. Sproule TJ; Wilpan RY; Wilson JJ; Low BE; Kabata Y; Ushiki T; Abe R; Wiles MV; Roopenian DC; Sundberg JP PLoS One; 2023; 18(10):e0293218. PubMed ID: 37883475 [TBL] [Abstract][Full Text] [Related]
18. BPAG1 in muscles: Structure and function in skeletal, cardiac and smooth muscle. Horie M; Yoshioka N; Takebayashi H Semin Cell Dev Biol; 2017 Sep; 69():26-33. PubMed ID: 28736206 [TBL] [Abstract][Full Text] [Related]
19. Genetic alterations at the Bpag1 locus in dt mice and their impact on transcript expression. Pool M; Boudreau Larivière C; Bernier G; Young KG; Kothary R Mamm Genome; 2005 Dec; 16(12):909-17. PubMed ID: 16341670 [TBL] [Abstract][Full Text] [Related]
20. One gene but different proteins and diseases: the complexity of dystonin and bullous pemphigoid antigen 1. Künzli K; Favre B; Chofflon M; Borradori L Exp Dermatol; 2016 Jan; 25(1):10-6. PubMed ID: 26479498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]